StonvexLoading…
StonvexStonvexStonvexCore line items from CCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $26.62B | $25.02B | $21.59B | $12.17B |
Operating Income | $4.48B | $3.57B | $1.96B | $-4.38B |
Net Income | $2.76B | $1.92B | $-74.00M | $-6.09B |
EPS (Diluted) | $2.02 | $1.44 | $-0.06 | $-5.16 |
Total Assets | $51.69B | $49.06B | $49.12B | $51.70B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.93B | $1.21B | $2.42B | $4.03B |
Free Cash Flow OCF − CapEx | $2.61B | $1.30B | $997.00M | $-6.61B |
Shares Outstanding | 1.40B | 1.40B | 1.26B | 1.18B |